ENMC APPROVED 5 WORKSHOP APPLICATIONS
ENMC is happy to announce that 5 workshop applications have been approved in the 2026 Spring review round. These workshops have been planned in January – April 2027.
More details: Workshops 2026-2027
ENMC is happy to announce that 5 workshop applications have been approved in the 2026 Spring review round. These workshops have been planned in January – April 2027.
More details: Workshops 2026-2027
We’re excited to share that new companies are joining the ENMC Company Forum in 2026!
A warm welcome to argenx and Avidity Biosciences, Inc., who will be joining our valued partners: Amicus Therapeutics International, Dyne Therapeutics, Lupin Pharmaceuticals, Novartis, Roche, Sanofi, Santhera Pharmaceuticals, and Sarepta Therapeutics.
We are deeply grateful for the continued and growing support of all our partners in advancing our shared mission: connecting people in the neuromuscular field.
Together, we strengthen collaboration, accelerate knowledge exchange, and drive progress for the neuromuscular community.
In the fifth call for the ENMC Mid-Career Mentoring Programme with the deadline July 2025, we received eight applications! Following interviews with each of the candidates, the ENMC Mentoring Programme Committee presented their recommendations to the Research- and Executive Committees. We are very happy to announce that six mentee candidates were selected for the programme:
More information about this programme, follow this link.
We are proud to present the ENMC Impact Report 2024! Read about our 2024 activities via this link.
If you would like to receive a printed copy, please send your request to enmc@enmc.org.
ENMC is happy to announce that 4 workshop applications have been approved in the 2025 Spring review round. These workshops will be planned in Q1 2026.
More details: Workshops 2025-2026
ENMC is happy to announce that 3 workshop applications have been approved in the 2024 Autumn review round. These workshops will be planned in Q2-Q4 2025.
More details: Workshops 2025
Glad to announce that ENMC has approved 7 workshop applications in the 2024 Spring review round. These workshops will be held in Q4 2024 and Q1 2025.
More details: Workshops-2024-2025-2805.pdf (enmc.org)
We are proud to present the ENMC Impact Report 2023! Read about our 2023 activities via this link.
If you would like to receive a printed copy, please send your request to enmc@enmc.org.
March 1st is the deadline to submit an application of a regular or themed ENMC workshop. Start preparing your submission!
More information on how to apply: https://lnkd.in/dPu4n5s4
Workshop # 274 19-21 January 2024
ENMC recommendations for optimizing bone strength in neuromuscular disorders. Organisers: Prof. L. Ward (Canada), Dr A. Moretti (Italy), Dr D. Weber (USA), Prof N. Voermans (NL)
Workshop # 275 9-11 February 2024
Seronegative Myasthenia Gravis (MG): an update paradigm for diagnosis and management. Organisers: Dr A. Evoli (Italy), Dr L. Maggi (Italy), Dr J. Palace (UK), Prof. J. Verschuuren (NL)
Workshop # 276 15-17 March 2024
ENMC recommendations on optimal diagnostic pathway and management strategy for patients with rhabdomyolysis worldwide. Organisers: Prof. P. Laforêt (France), Prof. J. Vissing (Denmark), Prof. N. Voermans (NL), Dr S. Bhai (USA)
ENMC
Lt. generaal van Heutszlaan 6
3743 JN BAARN
The Netherlands
+ 31- 35-5480481
enmc@enmc.org
